Sumitomo Mitsui Trust Group Inc. Buys 1,319,464 Shares of Schrödinger, Inc. (NASDAQ:SDGR)

Sumitomo Mitsui Trust Group Inc. raised its stake in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 60.2% in the 4th quarter, HoldingsChannel reports. The firm owned 3,510,518 shares of the company’s stock after purchasing an additional 1,319,464 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Schrödinger were worth $67,718,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Redwood Wealth Management Group LLC raised its position in shares of Schrödinger by 8.4% during the 4th quarter. Redwood Wealth Management Group LLC now owns 14,620 shares of the company’s stock valued at $283,000 after buying an additional 1,132 shares in the last quarter. KBC Group NV increased its stake in Schrödinger by 73.9% in the fourth quarter. KBC Group NV now owns 4,361 shares of the company’s stock valued at $84,000 after acquiring an additional 1,853 shares during the last quarter. Geneos Wealth Management Inc. raised its position in Schrödinger by 15.4% during the fourth quarter. Geneos Wealth Management Inc. now owns 59,996 shares of the company’s stock valued at $1,157,000 after purchasing an additional 8,021 shares in the last quarter. Avanza Fonder AB bought a new stake in Schrödinger during the fourth quarter worth about $577,000. Finally, GAMMA Investing LLC boosted its holdings in shares of Schrödinger by 87.5% in the 4th quarter. GAMMA Investing LLC now owns 2,796 shares of the company’s stock worth $54,000 after purchasing an additional 1,305 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Schrödinger Stock Performance

Shares of SDGR stock opened at $25.67 on Monday. The company has a market capitalization of $1.87 billion, a P/E ratio of -10.97 and a beta of 1.61. Schrödinger, Inc. has a fifty-two week low of $16.67 and a fifty-two week high of $33.63. The stock has a 50 day moving average price of $21.60 and a two-hundred day moving average price of $20.27.

Schrödinger (NASDAQ:SDGR) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.52) EPS for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). The firm had revenue of $35.30 million for the quarter, compared to the consensus estimate of $41.25 million. Schrödinger had a negative net margin of 91.84% and a negative return on equity of 35.77%. The company’s quarterly revenue was down 17.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.86) earnings per share. As a group, equities analysts predict that Schrödinger, Inc. will post -2.37 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on SDGR shares. BMO Capital Markets raised their price objective on Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Wednesday, November 13th. KeyCorp lifted their price target on shares of Schrödinger from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. Three equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, Schrödinger has an average rating of “Moderate Buy” and an average price target of $32.11.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.